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Background: Clustering of outcomes at centers involved in multicenter trials is a type of center effect. The
Consolidated Standards of Reporting Trials Statement recommends that multicenter randomized controlled trials
(RCTs) should account for center effects in their analysis, however most do not. The Early External Cephalic Version
(EECV) trials published in 2003 and 2011 stratified by center at randomization, but did not account for center in the
analyses, and due to the nature of the intervention and number of centers, may have been prone to center effects.
Using data from the EECV trials, we undertook an empirical study to compare various statistical approaches to
account for center effect while estimating the impact of external cephalic version timing (early or delayed) on the
outcomes of cesarean section, preterm birth, and non-cephalic presentation at the time of birth.
Methods: The data from the EECV pilot trial and the EECV2 trial were merged into one dataset. Fisher’s exact method
was used to test the overall effect of external cephalic version timing unadjusted for center effects. Seven statistical
models that accounted for center effects were applied to the data. The models included: i) the Mantel-Haenszel test,
ii) logistic regression with fixed center effect and fixed treatment effect, iii) center-size weighted and iv) un-weighted
logistic regression with fixed center effect and fixed treatment-by-center interaction, iv) logistic regression with
random center effect and fixed treatment effect, v) logistic regression with random center effect and random
treatment-by-center interaction, and vi) generalized estimating equations.
Results: For each of the three outcomes of interest approaches to account for center effect did not alter the
overall findings of the trial. The results were similar for the majority of the methods used to adjust for center,
illustrating the robustness of the findings.
Conclusions: Despite literature that suggests center effect can change the estimate of effect in multicenter trials, this
empirical study does not show a difference in the outcomes of the EECV trials when accounting for center effect.
Trial registration: The EECV2 trial was registered on 30 July 30 2005 with Current Controlled Trials: ISRCTN 56498577.
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The rise of evidence-based medicine has increased the
number of randomized controlled trials (RCTs) conducted
to test medical and surgical interventions [1]. Multicenter
trials are often used to accumulate large sample sizes in a
short time period, or to meet sample size requirements
that would be impossible within one center. The inclusion
of different centers and providers is beneficial in prag-
matic trials as it allows for the greater generalizability of
trial results. However, the potential variation between
centers poses methodological issues. Each center needs
to rigorously follow the study protocol, particularly
around inclusion and exclusion criteria, and the applica-
tion of the intervention to reduce heterogeneity and allow
for outcome results to be pooled. Furthermore, accurate
reporting of the characteristics of the centers involved in
the study can allow readers to assess the risk of bias and
the usefulness of the results [1,2].
The assumption made in many multicenter trials is
that participants recruited to the trial are independent of
each other. This assumption of independence is necessary
to apply routine statistical methods such as the Student’s
t-test or chi-squared test. However, management of indi-
viduals within the same trial center may be similar, leading
to the potential of outcomes from these individuals being
correlated with each other. It is not hard to imagine that
intervention success rates could differ from one center to
the next due to any number of combinations of practi-
tioner experience, nursing support and expertise, medical
equipment, and center-specific treatment practices. When
trial centers are in different international locales, the
dissimilarities could be magnified. The correlation of
outcomes among individuals within a study center is a
type of clustering described as a center effect. If center
effects are overlooked, incorrect effect estimates, confi-
dence intervals, and P values may be the result [2,3].
Many RCTs test non-pharmacologic treatments such
as surgery, technical procedures, devices, rehabilitation,
psychotherapy, behavioral interventions, and complemen-
tary and alternative medicine [4]. A review of all RCTs
published in 2000 revealed that 10% of RCTs are for
surgical or procedural interventions [5]. These trials
have specific issues compared to pharmacologic trials
because treatments are less standard and blinding is
more difficult [4]. The group responsible for the Con-
solidated Standards of Reporting Trials (CONSORT)
Statement published an extension of the Statement to
specifically guide researchers involved in RCTs of non-
pharmacologic treatments [4,6]. The Statement identifies
center characteristics such as provider skill and center vol-
ume that could impact patient outcomes. Since clustering
of outcomes at study centers may reduce statistical power,
the CONSORT group recommends accounting for cluster-
ing in sample size calculations and in statistical analyses [4].Despite the development of statistical methods to ac-
count for center effect and the recommendations by trial
reporting guidelines, evidence from reviews of the litera-
ture indicate that most individually randomized multicen-
ter trials do not account for center effect [1,7]. Biau et al.
conducted a systematic review of the account of center
and provider effects in large surgical and interventional
(non-pharmacological) RCTs [1]. A total of 68 multicenter
interventional randomized trials of more than 200 patients
between the years 2000 and 2005 met the inclusion criteria.
They found that stratification by center at randomization
was reported in 38% of trials and analysis adjusted for cen-
ter was reported in 6% of trials [1]. Tangri et al. published
a similar systematic review of the literature to assess the
extent of adjustment for center in RCTs of medicinal
products [7]. They included 101 multicenter RCTs pub-
lished in 2007 in four prominent medical journals. Of the
101 trials, 36% used random allocation stratified by center,
and 18% adjusted for center in the statistical analysis [7].
Both reviews concluded that improvements to trial report-
ing regarding center effects are needed. However, the lit-
erature provides little guidance and does not suggest one
preferred statistical method to account for center effects.
In fact, there is a lack of evidence on which models per-
form best in various situations [8].
The objective of this secondary analysis was to use a
combined dataset of the Early External Cephalic Version
(EECV) trials to demonstrate the use of available statistical
methods to account for center effects in multicenter trials.
The EECV trials had many centers and the main outcomes
were binary. We reviewed the literature for statistical ap-
proaches - both population-averaged and random-effects
models - which might fit with these study characteristics
[3,9-12]. We estimated the effect of external cephalic ver-
sion (ECV) timing (early or delayed) on the outcomes of
cesarean section, preterm birth, and non-cephalic presen-
tation at the time of birth without accounting for center,
and then assessed the consistency of the results under dif-
ferent methods of accounting for center.
The Early External Cephalic Version trials
ECV is an obstetric procedure undertaken during preg-
nancy to attempt to manually turn a fetus through the
maternal abdomen from the breech (buttocks down) pres-
entation to a cephalic (head down) presentation. The pilot
and full EECV trials were multicenter RCTs aimed at in-
vestigating the effectiveness of beginning ECV earlier in
pregnancy (conducted between 34 weeks and 0 days and
35 weeks and 6 days gestation) compared to the usual tim-
ing of ECV at full term (37 weeks and 0 days or beyond)
on pregnancy outcomes [13,14]. At the time of the EECV
trials, nearly all fetuses in the breech presentation at term
or at the onset of labor were born by cesarean section.
The primary outcome was the rate of cesarean section
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The study measured overall success of the ECV procedure
by including the rate of non-cephalic presentation at deli-
very as another outcome.
Eligible participants were women with a singleton
breech fetus at a gestational age of 33 weeks and 6 days
to 35 weeks and 6 days. Participants were randomly
assigned to have the first ECV procedure early or de-
layed, with stratification by center and parity to ensure
approximately equal numbers of early and delayed ECVs
at each center, as well as balance the number of multip-
arous women (a known predictor of ECV success) in
each group at each center.
Ethical approval was obtained for both the pilot trial
(The University of Toronto Office of Research Services)
and the EECV2 trial (The University of British Columbia
Clinical Research Ethics Board, reference number: C04-
0348 and the Research Ethics Board of Hamilton Health
Sciences Research Ethics Board, reference number:
07-122). Furthermore, ethical approval was obtained
from each of the sites where the recruitment took place.
Informed consent was obtained from each woman who
was enrolled in the trial.
The planned analysis called for Fisher’s exact test to
assess the relationship between the exposure (timing of
ECV procedure) and the primary and secondary out-
comes (cesarean section and preterm birth). The effects
of the intervention were reported using relative risks
(RR) and 95% confidence intervals (CI). Subgroup ana-
lyses were completed using logistic regression to test for
interactions between baseline characteristics and treat-
ment group for the primary and secondary outcomes.
None were found to be significant.
The EECV pilot trial recruited 233 women from 25
centers in 7 countries. There were non-significant de-
creases in the rates of cesarean section (RR 0.90; 95%
CI 0.76 to 1.08; P = 0.32) and non-cephalic presenta-
tion at birth (RR 0.86; 95% CI 0.70 to 1.05; P = 0.09) for
women in the early ECV group. There was a non-
significant increase in the rate of preterm birth for
women in the early ECV group (RR 1.42; 95% CI 0.56
to 3.59; P = 0.31) [13]. The clinically important findings
of the EECV pilot trial supported the funding of a full-scale
RCT.
The EECV2 trial recruited 1543 women from 68
centers in 21 countries. Women in the early ECV
group were less likely to have a non-cephalic presen-
tation at delivery (RR 0.84; 95% CI 0.75 to 0.95; P =
0.002), but the decrease in the cesarean section rate
remained statistically non-significant (RR 0.93; 95%
CI 0.85 to 1.02; P = 0.12), and the trend for an in-
crease in preterm birth was strengthened, though still
not statistically significant (RR 1.48; 95% CI 0.97 to
2.26; P = 0.07) [14].Methods
The data from the EECV pilot trial and the EECV2 trial
were merged using SPSS IBM Corp., Armonk, NY, USA
(version 19.0); SAS Institute Inc., Cary, NC, USA (version
9.2) and R Foundation for Statistical Computing, Vienna,
Austria (version 2.12.2) were used for the statistical ana-
lyses. Participants were excluded from analysis if they
withdrew from the trial, if they were lost to follow-up, or
if there was missing data for the outcomes of interest:
mode of delivery, gestational age at birth, or presentation
at birth (cephalic versus non-cephalic) (Figure 1).
Using the merged dataset, we calculated the conditional
maximum likelihood estimate of the odds ratio (OR) and
the exact 95% CI based on non-central hypergeometric con-
ditional likelihood using function ’exact2x2(…, tsmethod=
”minlike”,…)’ in the R package ‘exact2x2’ [15,16]. The CI
matched the usual two-sided Fisher’s exact test which
defines the P-value as the sum of probability of tables with
smaller likelihood than the observed table.
We chose methods to account for center effect that
functioned for data from a multicenter trial that used in-
dividual random allocation to group, stratified by center,
with binary outcomes. The methods are broadly grouped
as conditional and unconditional methods as follows. No
further research ethics approval was required to conduct
this secondary analysis.
Conditional methods
Conditional methods estimate treatment effects by strati-
fying (or conditioning) on center. These methods are ap-
propriate for multicenter trials in which participants are
randomly assigned to different treatment arms within each
center [3]. Conditional methods can be subdivided into
fixed- and random-effects models. A fixed-effects ana-
lysis considers a center to represent only itself, while a
random-effects analysis represents the population of
centers from which the study sample was drawn [3,17].
Accounting for center as both a fixed and random ef-
fect produces a single estimate of treatment effect if the
treatment effect is assumed to be constant across cen-
ters. If the treatment effect is suspected to be different
across centers, altering the model to include treatment-
by-center interaction can improve the model’s fit [3].
Trials that test procedural interventions, such as the
EECV trials, may be more likely to have heterogeneity
of treatment effects across trial centers due to the diffi-
culty of standardizing and administering the procedural
intervention in a consistent manner across study sites
[4]. Such heterogeneity may be reduced when a strict
study protocol is followed [4]. The interaction that
occurs when trial sites have different treatment effects
is also known as effect modification.
We used six different conditional methods to account
for center in the EECV trials. Four are fixed-effects
Figure 1 Trial flow diagram.
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gression with fixed center effect and fixed treatment ef-
fect, iii) logistic regression with fixed center effect and
fixed treatment-by-center interaction (weighted by cen-
ter size), and iv) logistic regression with fixed intercept
and fixed treatment-by-center interaction (un-weighted
by center size). Two are random-effects models: v)
logistic regression with random center effect and fixed
treatment effect, and vi) logistic regression with random
center effect and random treatment-by-center interaction.
Models including treatment-by-center interaction as either
fixed (iii and iv) or random effect (vi) allow for possible
effect modification in the EECV trials. The models are
described briefly below.
Mantel-Haenszel test
The Mantel-Haenszel test is a fixed-effects analysis that
summarizes data into a series of two × two tables based
on covariates or strata. The Mantel-Haenszel test is
often used when the trial has binary response variables
and only two treatment groups; however, it has been
generalized to analyze 2(response) × J(exposure) tables
[18,19]. The Mantel-Haenszel test performs well even
with sparse data and is suitable for studies like the EECV
trials that have many centers and few participants per
center [3,20]. The simplicity of the Mantel-Haenszel testis considered an advantage [20]. Centers that had only
one participant were removed from the analysis. The
statistical software program R Version 2.12.2 was used
to run the Mantel-Haenszel chi-squared test.
Logistic regression with fixed center effect and fixed
treatment effect
Fixed-effects regression estimates within-center treatment
effects [3]. It achieves this by including a separate inter-
cept for each center as a fixed effect, restricting the
inference of the results to included centers [8]. The
model works best when there are many participants
spread across few centers. Unreliable estimates can occur
when the majority of centers have few patients and few
events [3]. Since the EECV trials had low enrollment at
some centers, the deletion of some small centers was
expected for this model.
We used logistic regression with fixed center effect
(Equation 2) to model the impact of treatment (X)(1 =
early ECV, 0 = delayed ECV) on the odds of having the
outcome event:
Yð Þ 1 ¼ CS; 0 ¼ noCSð Þ πik
1−πik
ð1Þ
with a separate intercept for each center (k) as a fixed
effect. Let πik = P (Y = 1 | x = i, z = k), for i = 1, 0; k = 1, …,
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someone receiving treatment ith in the kth center. β0k
represents the log odds for the control group in center k,
and β1 represents the log odds ratio of the treatment
across all centers:
logit πikð Þ ¼ log πik1−πik ¼ β0k þ β1 X ð2Þ
Logistic regression with fixed center effect and fixed
treatment-by-center interaction (weighted and
un-weighted by center size)
Most analyses assume the absence of effect modification.
When effect modification is suspected or present, adding
an interaction term allows estimation of treatment effect
specific to each center. We used a fixed-effects logistic
regression model with treatment-by-center interaction to
account for the possibility that centers could have varying
treatment effects (Equation 3). Here, β1k represents the
log odds ratio of having the outcome in the treatment
group over the control group in the kth center:
logit πikð Þ ¼ β0k þ β1k X ð3Þ
The model was run twice: once with and once without
weighting by the size of the center (number of women
enrolled). In multicenter trials with large disparities in
center size, as was seen in the EECV trials, weighting by
center size prevents small centers from inflating the
variance [17]. The fixed-effects regression models were
fitted using proc genmod in SAS version 9.2.
Logistic regression with random-effect terms
Random-effects models are another way to model the
hierarchical structure of patients within centers in indi-
vidually randomized multicenter trials [21]. In contrast
to fixed-effects models that provide results relevant only
to the study sample, random-effects models are general-
ized to the entire population of possible centers by as-
suming that the trial centers are a random sample of all
centers. Although this may not be the way that centers
are chosen in a pragmatic RCT, the underlying notion is
that the results of the trial provide probabilistic statements
about patients in general, even those attending centers not
included in the trial [17]. A random-effects model can be
an improvement over a fixed-effects model when there are
many centers [17,22,23].
Random-effects models have been used for decades for
continuous outcomes, but model interpretation and fit-
ting is more difficult with binary data. Random-effects
models are also known by various other names such as:
center-specific, mixed-effects, variance component, hier-
archical, multistage, generalized linear mixed models, multi-
level models, or empirical Bayes regressions depending onthe context and subject area where the methods are applied
[3]. In this manuscript, we refer to a statistical model inclu-
ding one or more random-effect terms as a general
random-effects model. Two models incorporating random-
effects were used to adjust for center in the EECV trials.
Logistic regression with random center effect and fixed
treatment effect
A logistic regression model with random center effect and
fixed treatment effect, reflected in Equation 4, adjusts for
center effects assuming that though there may be cluster-
ing of outcomes across treatment arms in each center,
variation in the treatment effect is unlikely [21]. β0 is a
fixed intercept representing the average log odds of experi-
encing an outcome in the control arm. b0k is a random
variable representing how the log odds in center k deviates
from the overall log odds in the control arm. b0k follows a
Normal (0, σ2) distribution. The unknown parameter σ
summarizes center heterogeneity in the outcome probabi-
lities. β1 represents the single treatment effect over partici-
pating centers.
logit πikð Þ ¼ β0 þ b0k
 þ β1 X ð4Þ
Logistic regression with random center effect and
random treatment-by-center interaction
This model includes an additional random effect b1k, often
known as the random treatment-by-center interaction or
random treatment effect at each center [8,21]. By inclu-
ding random center effect and random treatment effect in
the model (Equation 5), we account for center heterogen-
eity in log odds in the control group and variation in treat-
ment effects across centers. (b0k, b1k) is assumed to follow
a bivariate normal distribution specified in Equation 6,
where σ20 and σ
2
1 represent the variance of the random
effects and σ12 = σ21 represents the covariance between b0k
and b1k.
logit πikð Þ ¼ β0 þ b0k
 þ β1 þ b1kð Þ X ð5Þ
b0k
b1k







We fit the random-effects logistic regression models
using function lmer() (lme4 package) in R version 2.12.2.
In a later version of R, glmer() has been introduced to
replace lmer() for fitting generalized linear random-effects
models. Refitting logistic regression models with random
effects using glmer() in R version 2.15.2 produced the
same results.
Unconditional methods
Unconditional methods include marginal or population-
averaged models that estimate an average treatment effect
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comes at centers [3]. One unconditional method, general-
ized estimating equations, was applied to the EECV trial
data.
Generalized estimating equations
Generalized estimating equations (GEE) model the mar-
ginal population treatment effects averaged across centers
in two steps [11]. First a model similar to ordinary logistic
regression without regard to the center is fitted. Then the
model is refitted to adjust the standard error and CIs for
within-center dependence. By using weighted combinations
of observations, the GEE approach extracts the appropriate
amount of information from correlated data [24]. Some
studies suggest a large number of centers (for example, 30)
is required for the underlying theory of the GEE model to
apply [3,12].
Application of the GEE model to the EECV trial data
was achieved using data in the same individual patient-
level format as was used for the random-effects regres-
sions. The GEE model was run using proc genmod assum-
ing exchangeable correlation structure in SAS Version 9.2.
Intra-class (or intra-center) correlation (ICC) values were
noted from the GEE output to present the magnitude of
differences in treatment effect between the centers.
Results
Center characteristics
The data from the EECV pilot trial and the EECV2 trial
were merged to create one large dataset (Figure 1). A
total of 81 centers from 22 countries contributed partici-
pants for the trials. Center sizes were unequal, with the
number of women recruited at each center varying from
1 to 117. There were a small number of centers that re-
cruited large numbers of participants, and a large number
of centers that recruited small numbers of participants.
The mean center recruitment was 45 and the median cen-
ter recruitment was 13. Random block sizes ensured that
approximately equal numbers of patients were random-
ized to the intervention and control groups at each center
(trial protocol, 2005). Overall, 881 were randomized to the
early ECV group and 883 to the delayed ECV group. The
recruitment rates and balance of stratification are pre-
sented in Figure 2.
The seven statistical models described in the methods
were applied to the EECV trial data to adjust for center
effects, and the results for three selected outcomes are
reported in Figures 3, 4, and 5.
Low-recruiting centers
Different methodological approaches required different
ways of handling low-recruiting, or ‘small’ centers in the
analyses. The Mantel-Haenszel test used data from 78
out of 81 centers after the three centers that enrolledonly one woman were removed from the analysis. For
the three fixed-effects regressions, centers had to be re-
moved from analysis if all the participants at that center
were in one treatment group, or if all the participants ex-
perienced the same outcome. The removal of these centers
was necessary because the statistical model is constructed
only with centers that provide sufficient statistics [20]. Dif-
fering numbers of centers were removed from the analysis
for the three outcomes of interest. A total of 71 centers
representing 1739 participants were included for the out-
comes of cesarean section and non-cephalic presentation
at birth; 46 centers representing 1434 women were in-
cluded for the outcome of preterm birth. Further centers
were removed from analysis when the treatment-by-center
interaction term was added to the fixed-effects regression
model due to zero counts in the interaction term. For the
outcome of cesarean section, 57 centers representing 1655
women were included, for preterm birth 14 centers repre-
senting 646 women were included, and for non-cephalic
presentation at birth, 57 centers representing 1649 women
were included in the analysis. The models, including a
random-effects term and the GEE, were run with the entire
dataset. Sparse center data does not cause problems for the
random-effects approach because parameter space does
not increase with the number of centers [20].
Performance of various approaches to adjust for center
effect
Outcome 1: cesarean section
ECV has been shown to reduce the risk of cesarean sec-
tion at term [25], but the EECV2 trial did not demonstrate
a statistically significant difference in cesarean section
rates when comparing early ECV with the routine practice
of conducting ECV at term [14]. The merged dataset was
analyzed using Fisher’s exact test and associated exact CI
estimation to provide an individual-level baseline analysis
to which the methods that account for center could be
compared. Unadjusted for center, the OR for cesarean
section for those in the early ECV group was 0.84 (95% CI
0.69 to 1.01; P = 0.07).
Using methods to adjust for center effect gave estimates
of effect that were similar to the unadjusted results
(Figure 3). The seven models that adjusted for center
effect provided ORs varying from 0.81 to 0.90, with
lower limit 95% CI varying from 0.67 to 0.70 and upper
limit 95% CI varying from 0.99 to 1.20. The least efficient
model was the logistic regression with fixed treatment-by-
center interaction term, un-weighted by center size, as
shown by the wider 95% CI of 0.68 to 1.2.
Outcome 2: preterm birth
The OR of preterm birth for women in the early ECV
group, unadjusted for center, was 1.48 (95% CI 0.97 to


















Figure 2 Center recruitment and balance of stratification. Center numbers: 1-22 (Canada); 23-28 (UK); 29-33 (USA); 34-46 (Australia); 47-51 (Israel);
52-53 (South Africa); 54-59 (Argentina); 60 (New Zealand); 61-65 (Chile); 66-67 (Denmark); 68 (Germany); 69 (Ireland); 70 (Jordan); 71-73 (The Netherlands);










Figure 3 Forest plot for Outcome 1: cesarean section. Mantel-Haenszel test included 78 centers and 1761 participants. Fixed-effects (1): logistic
regression with fixed center effect and fixed treatment effect, included 71 centers and 1739 participants. Logistic regression with fixed center effect and
fixed treatment-by-center interaction, both weighted (Fixed-effects (2)) and un-weighted by center size (Fixed-effects (3)), included 57 centers and 1655
participants. Random-effects (1): logistic regression with random center effect and fixed treatment effect, Random-effects (2): logistic regression with
random center effect and random treatment-by-center interaction, and GEE used all 81 centers and 1764 participants. CI, confidence interval,
GEE, generalized estimating equations, OR, odds ratio.











Figure 4 Forest plot for Outcome 2: preterm birth. Mantel-Haenszel test included 78 centers and 1761 participants. Fixed-effects (1): logistic
regression with fixed center effect and fixed treatment effect, included 46 centers and 1434 participants. Logistic regression with fixed center effect and
fixed treatment-by-center interaction, both weighted (Fixed-effects (2)) and un-weighted by center size (Fixed-effects (3)), included 14 centers and 646
participants. Random-effects (1): logistic regression with random center effect and fixed treatment effect, Random-effects (2): logistic regression with
random center effect and random treatment-by-center interaction, and GEE used all 81 centers and 1764 participants. CI, confidence interval,
GEE, generalized estimating equations, OR, odds ratio.
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using different models to account for center effect. In
two models, the odds of preterm birth for women in the
early ECV group reached statistical significance. These
were the Mantel-Haenszel test (1.55; 95% CI 1.01 to 2.37)
and the first fixed-effect model (logistic regression with
fixed center effect and fixed treatment effect; 1.57; 95% CI
1.02 to 2.43). In contrast, in the models that included a
fixed treatment-by-center interaction term (both weighted
and un-weighted by center size), the point estimates are
closer to the null value and the CIs are wider, but the re-
sults are based on data from only 14 centers. As shown in
Figure 4, the overall results for the preterm birth outcome
do not indicate that the adjusted results are very different
from the unadjusted results.
Outcome 3: non-cephalic presentation at birth
Unadjusted for center, the OR of having a baby in a non-
cephalic presentation at the time of birth was 0.72 (95%
CI 0.60 to 0.88; P = 0.001) for women in the early ECV
group compared to the delayed ECV group.
The adjusted results confirm that those in the early ECV
group were more likely to have a cephalic presentation at
the time of birth and indicate robust results under differentmethods of adjusting for center (Figure 5). The OR varied
from 0.70 to 0.72 among six out of seven statistical models.
The seventh model, logistic regression with fixed cen-
ter effect and fixed treatment-by-center interaction un-
weighted by center size, resulted in much wider CIs
and a non-significant result. This deviation is likely
due to the equal weighting of small centers with larger
centers.
Magnitude of between-center differences
ICC was calculated for each of the three outcomes to
quantify the average correlation between outcomes within
the same center. For cesarean section, the ICC was 0.036,
for preterm delivery the ICC was 0.014, and for non-
cephalic presentation at birth the ICC was 0.048. These
values suggest that the power to detect a treatment effect
could be underestimated by approximately 0.5 to 4.0% [23].
Discussion
Seven statistical models, available in the statistics litera-
ture, were applied to data from the EECV trials to pro-
vide researchers with an empirical example of accounting
for center in a multicenter trial with binary outcomes.










Figure 5 Forest plot for Outcome 3: non-cephalic presentation at birth. Mantel-Haenszel test included 78 centers and 1761 participants. Fixed-
effects (1): logistic regression with fixed center effect and fixed treatment effect, included 71 centers and 1739 participants. Logistic regression with fixed
center effect and fixed treatment-by-center interaction, both weighted (Fixed-effects (2)) and un-weighted by center size (Fixed-effects (3)), included 57
centers and 1649 participants. Random-effects (1): logistic regression with random center effect and fixed treatment effect, Random-effects (2): logistic
regression with random center effect and random treatment-by-center interaction, and GEE used all 81 centers and 1764 participants. CI, confidence
interval, GEE, generalized estimating equations, OR, odds ratio.
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dependent of others at the same centre may reduce
the statistical power needed to show a treatment effect
when the clustering of outcomes occurs. Our results
show how changing statistical assumptions can con-
firm the magnitude of the treatment effect and builds
on previous works addressing statistical analysis in
multicenter trials [8,26,27].
As we applied statistical models to adjust for center ef-
fect, issues arose that may be of interest to researchers
attempting similar adjustment. Low-recruiting centers were
problematic in the application of fixed-effects logistic re-
gression models. Centers that contain only patients of one
treatment group or experiencing only one type of outcome
event need to be removed. Since patients at small centers
provide little information to overall treatment effect, re-
moving them may not cause a problem [20] and this was
confirmed in our results. However, when an interaction
term is added to the equation, further centers need to be
dropped, particularly for rare outcomes, and the resultant
findings display low precision. We also illustrated the
effect that weighting (or not weighting) by center size
has on the logistic regression with fixed center effect
and fixed treatment-by-center interaction. Our resultsfor the un-weighted model have the widest CIs and most
different effect estimates than any other model, confirming
the work of Senn that weighting small and large centers
equally can actually increase the variation around the
estimate [17].
GEE was the one unconditional method applied to the
dataset. GEE uses covariance matrices and/or structures
to estimate correlation within centers that are inherently
weighted to center size. GEE was well suited to the EECV
trial data where there were many centers and the center
size varied widely. The small difference between results
from the GEE approach and the conditional methods may
be partly explained by the non-collapsibility of ORs with
non-null treatment effects [28].
Missingness in the EECV trial dataset used in this study
was unlikely to have influenced the results of these analyses
because it was not substantial. When the outcome is miss-
ing completely at random, GEE yields consistent estimators
of the regression parameters, provided the model for the
mean is correctly specified. Likelihood-based methods such
as random-effects models may be a better alternative when
missingness is at random [29-32]. When missingness de-
pends on the unobserved outcomes, none of the methods
can guarantee an unbiased estimate of effect.
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http://www.trialsjournal.com/content/15/1/377This secondary analysis adds to the knowledge base
regarding center effect in multicenter RCTs. A study by
Kahan and Morris [33] looked at clustering in individual
randomized trials by using both a case study and a
simulation. They concluded that clustering by recruitment
center is ‘non-ignorable’ when both patient outcomes and
treatment assignments are correlated within clusters. Their
simulation indicated that adjusting for center gave correct
type 1 error rates. In future research trials, protocols ought
to include plans to account for center effect, especially
as starting with the sample size calculation as the
magnitude of center effect can even change the sample
size required [34].
Conclusions
Awareness of the center effect in multicenter RCTs is
growing as literature describing its occurrence accumu-
lates. We conducted a secondary analysis of the EECV
trials - large obstetric trials that included many centers
with a wide range of recruitment rates in various inter-
national locales - to adjust for center effect. Our results
did not change the overall conclusions of the EECV trials,
however, adjusting for center effect increases confidence
in the results by illustrating the robustness of the study
findings under different statistical assumptions. This
secondary analysis provides an example to support clinical
researchers in their pursuit to adjust for center effect in the
design, analysis, and interpretation of multicenter RCTs.
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